1 / 48

Transfusion Medicine

Transfusion Medicine. Cheryl Pollock 13 November 03. Objectives. An understanding of: Available blood products Appropriate selection of blood products according to the clinical setting Potential complications of the transfusion. Outline. Blood banking Emergency transfusions

rhian
Download Presentation

Transfusion Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transfusion Medicine Cheryl Pollock 13 November 03

  2. Objectives • An understanding of: • Available blood products • Appropriate selection of blood products according to the clinical setting • Potential complications of the transfusion

  3. Outline • Blood banking • Emergency transfusions • Transfusion reactions and risks • Component therapy

  4. Blood Bank Basics • Type & screen • Blood group (ABO) identification • Rh typing • Antibody screening • Cross-matching

  5. ABO Identification • >400 RBC antigens have been identified • Major ones are ABO type, and Rh type • Anti-ABO Abs are IgM that bind complement and cause agglutination and destruction of red cells => acute intravascular hemolysis • Presence of A&B antigens are determined by testing with anti-A and anti-B Abs

  6. ABO Compatibility

  7. Rh Typing • Major Rh system Ag is the ‘D’ Ag • Rh status determined by testing with anti-D antibodies • Rh-neg females of child-bearing age always get Rh neg blood products • Rh-neg males and elderly females can get Rh-pos blood if emergent transfusion required

  8. Antibody Screening • To determine presence of: • Complete (agglutinating) antibodies • Agglutinate RBCs in saline • Usually IgM • Responsible for HTR • Incomplete (non-agglutinating) antibodies • special techniques to visualize agglutination • Usually IgG • Not responsible for HTR

  9. Antibody Screening • All antibody screens are negative • Patient has no unexpected anti-bodies • Donor blood released after an abbreviated or electronic cross-match • Any antibody screens are positive • Patient has one/more unexpected antibodies which need identification • Donors must be antigen-negative • Full cross-match required

  10. Antibody Screening:Coombs Test • Direct Coombs: • To detect Abs or complement on surface Ags of RBCs • Agglutination= IgG antibodies in the patient’s serum have bound to recipient RBCs • Indications: • Hemolytic disease of newborn • Hemolytic anemia • Hemolytic transfusion reaction

  11. Antibody Screening:Coombs Test • Indirect Coombs • Indirect antiglobulin test • Detect Abs in serum that can recognize Ags on RBC. • i.e. detect Abs capable of hemolysing RBCs • By mixing serum with donor RBC and then anti-antibody Abs: RBC agglutination = +test • Indications: • Cross-matching -bl gr Abs in pregnant pts • Atypical bl gr

  12. Pre-transfusion Testing • Donor • ABO and Rh status confirmed • Recipient • Abo and Rh determined • Antibody screening • For 18 clinically-relevant antigens • Indirect Coombs • If positive: specific identification, transfusion ideally delayed

  13. Cross-Matching • Test of donor/recipient RBC compatibility • Immediate “spin” cross-match • Recipient serum + donor RBCs, spin tube, read immediately • Detects ABO incompatibility only • Complete cross-match • If antibody screen + • Donor units w/out specific Ag are each tested with indirect Coombs

  14. Cross-Matching • Electronic cross-match • Donor blood issued based on blood bank info • Recipient’s ABO and Rh type has been done twice and filed in computer • No clinically significant antibodies found in current or past blood samples • Contraindications: • Significant antibodies present (current or past)

  15. Emergency Transfusions • PRBCs are the only blood product that can be used for emergency transfusion • Plasma products contain too many Abs • Patient stability and the time available before intervention is needed will determine what is chosen • Prior to transfusion, draw blood for typing and cross-matching

  16. Indications for ED Transfusion • Consider • Comorbidity -Cardiac status • Rate of bleeding • Acute/subacute bleed with impaired oxygen delivery to tissues • Hb <60-70 g/L • Symptomatic chronic anemia with Hb <60-70 g/L • Pre-op

  17. Pediatric Pearls • Hemodynamic parameters can be deceiving • Normotensive until ~30% blood volume lost acutely • In pediatric trauma, emergency transfusion of >20 ml/kg is associated with increased mortality

  18. Emergency transfusions • Case 1 • 56 y.o. male, motorcycle vs. car, with open femur fracture, unstable pelvis • HR 130, bp 80/50, intubated at scene for GCS=6. • Blood? How soon?

  19. Emergency Transfusions • Universal Donor Group O • Uncross-matched type O+ • Indications • Massive, uncontrolled hemorrhage from any cause • e.g. trauma, massive GI bleed, ruptured AAA • Women of child-bearing age need group O-

  20. Emergency Transfusions: Other Options • Type-Specific: • 5-10 min • ABO grouping, Rh typing • pt can be initially stabilized with crystalloid • Incomplete cross-match • 30 min • ABO group, Rh type, “spin” cross-match • Fully cross-match • 45-60 min • Reserved for specific patient for 48h

  21. Administration • PRBCs • 1 unit= 250ml, Hct= 60-70% • 1 unit= 10 g/L increase in Hb • Peds: 1ml/kg PRBCs = 1% increase in hematocrit • Bedside check • Recipient & unit i.d., compatibility, expiration • Large-bore needles to prevent hemolysis • Blood warmers if massive transfusion • Blood only mixed with NS; no meds in same IV line

  22. Complications • Transfusion reaction • Immediate • Delayed • Infectious disease transmission • Transfusion-associated coagulopathies

  23. Immediate Hemolytic Intravascular Non-hemolytic Febrile Allergic Acute lung injury Hypervolemia Delayed Hemolytic (extravascular) Infectious Graft v. Host disease Electrolyte imbalance Transfusion Reactions

  24. Transfusion Reactions • Case 2 • 70 y.o. male transfused for UGI bleed • Transfusion of first unit PRBCs • Acutely dyspneic, chest and low back pain, with burning at IV site. • O/E: T 39C; HR 120; BP 100/60

  25. Acute Hemolytic Transfusion Reaction (Intravascular) • Medical emergency due to ABO incompatibility (usually clerical error) • Incompatible donor cells are destroyed by recipient antibodies • Intravascular cell lysis=> hemoglobinemia and hemoglobinuria • Incidence ~1/20 000 transfusions • Fatal 1/100 000 transfusions

  26. Acute Hemolytic Transfusion Reaction • Presentation • chills, headache, N/V, burning at infusion site, • Chest tightness, dyspnea, low back pain • O/E: fever, tachycardia, hypotension • Complications • Cardiogenic shock, respiratory failure • ATN • DIC

  27. Acute Hemolytic Reaction:Treatment Principles • Prevention • Slow infusion for 15 min, Q5min VS • STOP THE TRANSFUSION • Replace IV tubing • ABCs • Hemodynamic stability: crystalloid+/- pressors • Adequate renal blood flow • Low-dose dopamine infusion • Urine output >100ml/h (fluid + furosemide)

  28. Acute Hemolytic Reaction • Evaluation • Retype and cross-match • Direct & indirect Coombs • CBC, creatinine, PT/PTT • Haptoglobin, indirect BR, LDH, plasma free Hb • Urine for Hb

  29. Immediate Transfusion Reactions • Non-hemolytic • Febrile • Allergic • Acute lung injury • hypervolemia

  30. Transfusion Reactions • Case 3 • 58 y.o. female post-elective TAH. • During transfusion of 1st unit PRBCs, c/o malaise, chills, ‘feels warm’. • O/E: T 39C; HR 90; BP 120/80

  31. Immediate Transfusion Reactions • Febrile non-hemolytic • Impossible to clinically distinguish from acute hemolytic reaction • Caused by Ag-Ab reaction involving plasma/components passively transfused • Usually mild • Worse if poor CV status, critically ill • Multi-transfused, multiparous patients

  32. Febrile Non-hemolytic Reaction • Presentation • Fever, chills • Mgmt • Stop transfusion; • Initial Rx as per acute hemolytic reaction • Acetaminophen, meperidine • Evaluation • Hemolytic W/U +/- infectious W/U

  33. Allergic Transfusion Reaction • Anaphylaxis • Rare (1/20 000 transfusions) • Suggests IgA deficiency • Presentation • Dyspnea, bronchospasm, shock • Mgmt • Epi, steroid, anti-histamine, pressors • Do not restart transfusion • Hemolytic W/U

  34. Allergic Transfusion Reaction • Minor • Presentation • Urticaria, pruritis, erythema • Mgmt • Stop transfusion • Anti-histamine • If symptoms resolve, can restart transfusion • No further W/U

  35. Transfusion-Related Acute Lung Injury • Anti-WBC donor Abs + recipient WBC -> complement activation in lung -> non-cardiogenic pulmonary edema • Clinical diagnosis • Empiric treatment with steroids and respiratory support • Usually resolves within 48-96h

  36. Delayed Transfusion Reactions • Extravascular hemolytic transfusion reaction • Days to weeks • Non-ABO Abs bind to RBCs -> deformation -> splenic sequestration -> extravascular hemolysis • Presentation • Mild reaction • Fever, jaundice; hemoglobinuria rare • No specific treatment

  37. Delayed Transfusion Reactions • All blood tested for: • HIV Ag -HTLV I,II -HBsAg -syphilis • Ab to HIVI, II -HCV -HCAg • Infectious • Hep A 1: 1 000 000 • Hep B 1: 30 000- 1: 250 000 • Hep C 1: 30 000 – 1: 150 000 • HIV 1: 200 000 – 1: 2 000 000 Data from Goodnough et al. NEJM 340:440, 1999

  38. Delayed Transfusion Reactions • Case 4 • 44 y.o. male with Non-Hodgkin’s lymphoma 1/52 post-chemo • c/o fatigue, presyncope, SOBOE • Hb 68 • Risks of transfusion….

  39. Graft v. Host Disease • Rarely encountered in ED • Keep in mind if considering transfusion in anemic leukemic/lymphoma pts • Viable lymphocytes transfused with PRBCs • Multiplying, histoincompatible lymphocytes attack recipient->more BM suppression

  40. Graft v. Host Disease • Sx • Fever, N/V, rash, diarrhea, hepatomegaly • Increased LFTs, pancytopenia • No effective treatment • Fatal • Prevention • Gamma irradiation of all cell components, rendering donor lymphocytes incapable of proliferating

  41. Delayed Transfusion Reactions • Electrolyte imbalance • Hypocalcemia • Citrate preservative. • Hyperkalemia • K+ leakage across membrane • Problem in renal failure, neonates

  42. Dilutional Coagulopathy • Massive transfusion • Dilution of platelets & coagulation factors • Check platelets & coags after 5-10u PRBC • Platelet transfusion only if thrombocytopenia+microvascular bleeding • FFP only if PT/PTT >1.5x norm

  43. Component Therapy • Platelets • FFP • Cryoprecipitate

  44. Platelet Transfusion • Indications • count < 20 x 109/L; < 50 x 109/L if bleeding or planned invasive procedure • Therapy • Should be ABO-specific • Usually 6u at a time: increase of 50-60 x109/L • BUT…consider cause of thrombocytopenia • DIC, splenomegaly, antibodies may be refractory to platelet transfusion

  45. Fresh Frozen Plasma • All coagulation factors + fibrinogen • Indications • Emergent reversal of warfarin therapy • Correction of coagulation deficiencies • Therapy • Must be ABO compatible • 1u = ~250ml • Dose 10-15 ml/kg

  46. Cryoprecipitate • Contains • Factor VIIIC, vonWillebrand Factor, fibrinogen • Indications • Bleeding associated with: • Hypo-/dysfibrinogenemia (e.g. DIC) • vonWillebrand’s disease if FVIII not available • Hemophilia A if FVIII not available • Therapy • Should be ABO compatible (no cross-match) • Usual dose ~ 10u

  47. References • Marx: Rosen’s Emergency Medicine: concepts and Clinical Practice, 5th ed. • Tintinalli. Emergency Medicine: A Comprehensive Study Guide, 5th ed. • Ross, AK. Pediatric trauma. Anesthesia management. Anesthesiol Clin North Amer. 01 June 2001; 19(2): 309-37

More Related